BAX - NEW YORK STOCK EXCHANGE, INC.
Industry: Health Care
Market Cap: 15.9 B
IPO Date: May 15, 1961
Country: US
Currency: USD
Shares Outstanding: 512.9 M
5/8/2025
Baxter International Inc. stock outperforms competitors on strong trading day
Source: MarketWatch
5/8/2025
Explore Baxter International's potential turnaround as a divestiture boosts its balance sheet. Discover if years of double-digit returns await.
Source: SeekingAlpha
5/7/2025
Baxter International ( NYSE:BAX ) First Quarter 2025 Results Key Financial Results Revenue: US$2.63b (down 27% from 1Q...
Source: Yahoo
5/6/2025
DEERFIELD, Ill., May 06, 2025--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share of common stock. The dividend is payable on July 1, 2025, to stockholders of record as of May 30, 2025. The indicated annual dividend rate is $0.68 per share of common stock.
Source: Yahoo
5/6/2025
Baxter International Inc: * BAXTER INTERNATIONAL INC - DECLARES QUARTERLY DIVIDEND OF$0.17PER SHARESource text:Further company coverage: ...
Source: Finnhub
5/6/2025
Baxter International Inc. stock underperforms Tuesday when compared to competitors
Source: MarketWatch
5/6/2025
The growth stock trade that had propelled US stocks higher from late 2022 came undone in Q1. Read more here.
Source: SeekingAlpha
5/2/2025
Baxter International Inc (BAX) reports a robust first quarter with a 5% sales increase and EPS exceeding guidance, despite macroeconomic challenges.
Source: Yahoo
5/2/2025
Q1 2025 Baxter International Inc Earnings Call
Source: Yahoo
5/1/2025
Baxter International Inc. stock underperforms Thursday when compared to competitors
Source: MarketWatch
5/1/2025
Baxter reports better-than-expected first-quarter results. However, the company's gross margin contracts. Shares rise in pre-market.
Source: Yahoo
5/1/2025
Healthcare company Baxter International (NYSE:BAX) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 5.4% year on year to $2.63 billion. On the other hand, next quarter’s revenue guidance of $2.82 billion was less impressive, coming in 0.5% below analysts’ estimates. Its non-GAAP profit of $0.55 per share was 13.8% above analysts’ consensus estimates.
Source: Yahoo
5/1/2025
While the top- and bottom-line numbers for Baxter (BAX) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Source: Yahoo
5/1/2025
The following slide deck was published by Baxter International Inc.
Source: SeekingAlpha
5/1/2025
Baxter International Inc. (NYSE:BAX) Q1 2025 Earnings Conference Call May 1, 2025 8:30 AM ETCompany ParticipantsClare Trachtman - Senior Vice President and...
Source: SeekingAlpha
5/1/2025
Boosted by a surge in non-essential surgical procedures, manufacturers such as Baxter expect the rise in the sale of medical devices to counter the impact of U.S. President Donald Trump's levies. "While today's global macroeconomic factors are creating a greater degree of uncertainty in the market, we remain confident in our overarching trajectory," interim CEO Brent Shafer said. First-quarter sales at Baxter's medical products and therapies unit, which includes IV solutions, rose 3% to $1.26 billion from a year ago.
Source: Yahoo
5/1/2025
DEERFIELD, Ill., May 01, 2025--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2025.
Source: Yahoo
5/1/2025
BAXTER - PAGE 9 BAXTER INTERNATIONAL INC. Consolidated Statements of Income Three Months Ended March 31, ...
Source: Finnhub
4/30/2025
The medical device industry is growing fast in 2025, but faces supply and trade issues. Major companies to report earnings on May 1, stay tuned!
Source: Yahoo
4/30/2025
Healthcare company Baxter International (NYSE:BAX) will be announcing earnings results tomorrow before market hours. Here’s what to look for.
Source: Yahoo